AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06570642 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Goals mHealth Intervention
Description: On days participants plan to exercise, they engage in two daily goal sessions (morning and evening). Morning sessions provide an activity goal for the day and ask the participant to create a plan, anticipate barriers, and brainstorm solutions for achieving this goal. The affect-based goal condition asks participants to engage in either (1) a type (50% of daily goals) or (2) a context (50% of daily goals) of physical activity that allows them to experience positive affect. Goals focused on context are randomly generated to suggest that the participant performs activity (1) in a place; (2) in a social situation; or (3) while listening to something that makes them feel good. The intensity-based goal condition asks participants to maintain a certain target heart rate range during physical activity. Starting heart rate reflects the approximate age-adjusted heart rate max, with goals progressively increasing from 55% to 70% heart rate max.
Study NCT06570642 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TYPE/CONTEXT enhancement
Description: TYPE/CONTEXT augments intervention effects by providing tailored recommendations for activity types and contexts that satisfy personally-important psychological needs as rated by each participant at baseline. Ratings from a crowdsourced panel of adults on Amazon Mechanical Turk will be used to determine the potential for specific activity types and contexts to satisfy psychological needs; our tailoring algorithm will then recommend the corresponding activity type or context while accounting for reported constraints (e.g., ability, access). These details will be incorporated into a tailored recommendation provided to participants each Sunday as they make activity plans for the upcoming week. Specifically, the program will randomly select either type or context (i.e., location, audio, social) recommendations and will rotate every two weeks. For TYPE, participants' top 3 activity types are recommended; for CONTEXT, participants' top 3 activity contexts are recommended.
Study NCT06570642 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SAVOR enhancement
Description: SAVOR implements a brief savoring exercise on the smartphone that takes place either after the planned physical activity session or during the evening goal session (after the self-monitoring module). Participants will respond to questions that are intended to enhance and prolong positive experiences during physical activity. To trigger attentional deployment, a common savoring strategy that involves intensifying experiences by focusing on them, participants will answer three open-ended prompts. These prompts are drawn from a prompt pool with slightly varied wording to promote a sense of novelty. Savoring prompts will rotate daily and have a day lag built in every week (i.e., Week 1 Monday Savoring Prompts are Week 2 Tuesday Savoring Prompts).
Study NCT05633056 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Adherence support intevention
Description: Compare the effects of adherence support interventions on clinical and biological endpoints using an adaptive randomized platform.
Study NCT06570083 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Exercise Support
Description: Participants receive three months of personalized support via WeChat, including tailored exercise recommendations, motivational messages, and educational content.
Study NCT06570083 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-help physical activity booklet
Description: Participants receive a self-help booklet to promote physical activity among the elderly. The booklet will include guidelines for safe and effective exercises, tips for staying motivated, and information on the health benefits of regular physical activity.
Study NCT06570083 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-help physical activity booklet
Description: Participants receive a self-help booklet to promote physical activity among the elderly. The booklet will include guidelines for safe and effective exercises, tips for staying motivated, and information on the health benefits of regular physical activity.
Study NCT05939622 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Structural and functional MRI
Description: MRI using a Siemens MAGNETOM Prisma 3T scanner before and after a course of therapy, using resting state fMRI and with cognitive paradigm.
Study NCT05939622 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Structural and functional MRI
Description: MRI using a Siemens MAGNETOM Prisma 3T scanner before and after a course of therapy, using resting state fMRI and with cognitive paradigm.
Study NCT05939622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethyl methyl hydroxypyridine succinate + Meldonium
Description: Ethyl methyl hydroxypyridine succinate 100.0 mg/mL, meldonium dihydrate - 100.0 mg/mL (Solution for intravenous and intramuscular administration)
Study NCT05939622 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo was used in the same way
Study NCT06377644 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Kinesio taping is a physiotherapy method employed to provide support and stability to muscles and joints while allowing freedom of movement (ROM). The elastic nature of kinesio tape closely resembles that of human skin. After application, kinesio tape rebounds, generating a pulling force that acts as the primary stabilizer for the specific area. Physiotherapy treatments often involve a combination of stretching and strengthening exercises, along with electrotherapy modalities. Additionally, Joint mobilization is a form of passive movement in a broad spectrum of exercise used to treat painful and stiff synovial joints.
Study NCT06377644 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Dry Needling
Description: Dry needling is a minimally invasive technique involving the use of a single filament or acupuncture needle to penetrate painful soft tissue areas. From a neurophysiological standpoint, Dry Needling might stimulate A-delta nerve fibers (group III), which could activate inhibitory dorsal horn interneurons containing enkephalin, leading to pain suppression and relief through opioid mechanisms. (DN) may affect microcirculation. Numerous studies have shown that inserting needles into muscles can increase blood flow in both the skin and the muscle in the treated area. It can lead to an immediate reduction in local and referred pains, as well as enhance range of motion (ROM) and correct muscle activity patterns.
Study NCT04487860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AS012
Description: oral administration
Study NCT04487860 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral administration
Study NCT05523362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dexcom continuous glucose monitor
Description: The investigational device used in this study is the Dexcom G6 Pro/Personal Continuous Blood Glucose Monitoring system.
Study NCT05955378 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DSR Ankle
Description: This is the experimental ankle component used in the overall prosthetic intervention.
Study NCT05955378 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Predicate Ankle
Description: This is the participant's prescribed ankle/foot complex used in the overall prosthetic intervention.
Study NCT04926766 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam radiotherapy using IMRT technique
Description: 2600cGy/ 5 fractions / 1 weeks to ipsilateral whole breast and a sequential tumor bed boost of 5.2 Gy in 2 fractions at the discretion of radiation oncologist
Study NCT06156943 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: individualized goal-directed fluid therapy by Starling device
Description: For patients in optimized group, fluids will be managed by Starling device during the lung resection surgery.
Study NCT06156943 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: group managed by standard of care
Description: Patients will be managed intraoperatively at the discretion of the attending anesthesiologists, in accordance with their institutional protocols
Study NCT05578612 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dorsal Spanning Bridge Plate Fixation
Description: Dorsal spanning bridge fixation will be performed by board-certified orthopedic surgeons per standard technique.
Study NCT05578612 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dorsal Spanning Bridge Plate Fixation
Description: Dorsal spanning bridge fixation will be performed by board-certified orthopedic surgeons per standard technique.
Study NCT05578612 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dorsal Spanning Bridge Plate Removal
Description: Dorsal spanning bridge removal will be performed by board-certified orthopedic surgeons per standard technique.
Study NCT05578612 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dorsal Spanning Bridge Plate Removal
Description: Dorsal spanning bridge removal will be performed by board-certified orthopedic surgeons per standard technique.
Study NCT04971044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COACH
Description: Multi-Level Behavioral Intervention
Study NCT04971044 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: School Readiness Intervention
Description: Multi-Level Language and School Readiness Intervention (Control Group)
Study NCT06478173 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Exercise training will be performed as supervised small sided soccer games (3v3 to 7v7) 3 times a week for 14 weeks. Each session will last \~1 hour. Patients allocated to soccer training will undergo a ramp-up phase consisting of walking soccer training during weeks 1 and 2, after which normal soccer training will be applied from weeks 3 to 14.
Study NCT05650450 — intervention group
Intervention type: DEVICE
Intervention: DES+DCB
Description: Hybrid approach is defined as overlapping or slightly (2-3 mm) superimposing a new generation DES for a de novo long (>38 mm) lesion (located in the larger, more proximal part of the vessel -reference vessel diameter -RVD >2.75 mm-) and DCB inflation for a concomitant and contiguous de novo small vessel disease (distally located with RVD ≤2.75 mm ≥ 2.0 mm)
Study NCT05501158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: Suggesting an increase in the dose of tamoxifen to those who have suboptimum level of endoxifen due to their genetic variations
Study NCT05497245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mobile app-based breastfeeding education
Description: The main screen of the application used to be six screens. These six screens; Breastfeeding, Expressing, Contingencies, Frequently asked questions and my Breastfeeding Log and Breastfeeding diary. Mothers could record the number and duration of breastfeeding, milking status, the baby's height and weight, if it was a measure, the breastfeeding problem and solutions they encountered, on the Breastfeeding Introduction tab, and they could follow their breastfeeding status in the Breastfeeding Diary tab.
Study NCT04808011 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intelligent Dialysis Assistant (IDA)
Description: The IDA is intended for home dialysis for subjects who are stage 5 kidney diease patients and who perform Peritoneal Dialysis. The system is used deveral times a day for approximately 20 minutes for each cycle. During the interventional period, subjects will use only the investigational IDA system for their in/out exchanges.
Study NCT06304012 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric tube feeding
Description: The patients in the control group were provided nutrition support with Nasogastric tube feeding, while the feeding process strictly followed the relevant guideline. During the treatment, the patients remained in a continuous state of tube indwelling, receiving feeding every 2-3 hours with a maximum feeding volume of 200ml, of which the contents were consistent with the observation group. The entire feeding process was conducted by trained nursing staff. Besides, the tube was replaced by a new one every 5-7 days.
Study NCT06304012 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: The entire feeding process strictly followed the standard procedure of Intermittent Oro-esophageal Tube Feeding(18). During the feeding process, patients were maintained in a semi-recumbent position with their head elevated, facilitating the placement of the tube into the oral cavity along one side, with the chin brought close to the manubrium sterni.
Study NCT06304012 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy
Description: Acupuncture: Regular acupuncture treatment that can prevent muscle atrophy, improve circulation, and have a stimulating effect.~Exercise therapy: Training that focused on limb movements or joint mobilization to prevent muscle contracture, reduce joint mobility, improve spasms, and promote blood circulation.~Others: Regular turning, back patting, and position changes performed by caregivers.
Study NCT06304012 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation therapy
Description: Acupuncture: Regular acupuncture treatment that can prevent muscle atrophy, improve circulation, and have a stimulating effect.~Exercise therapy: Training that focused on limb movements or joint mobilization to prevent muscle contracture, reduce joint mobility, improve spasms, and promote blood circulation.~Others: Regular turning, back patting, and position changes performed by caregivers.
Study NCT05525208 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 subunit protein recombinant vaccine
Description: SARS-CoV-2 RBD subunit recombinant protein, manufactured by PT. Bio Farma
Study NCT05525208 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Active Comparator
Description: The Pfizer-BioNTech® COVID-19 vaccine or BNT162b2, is an mRNA vaccine encoding a P2 mutant spike protein (PS 2) and formulated as an RNA-lipid nanoparticle of nucleoside-modified mRNA (modRNA).
Study NCT06268210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lazertinib+Pemetrexed+Carboplatin
Description: Lazertinib: 240 mg once daily (pre-/post-surgery for 3 years) Pemetrexed: 500 mg/m2 every 3 weeks (neoadjuvant therapy for 3 cycles) Carboplatin: AUC5 every 3 weeks (neoadjuvant therapy for 3 cycles)
Study NCT06268210 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lazertinib
Description: Lazertinib will be administered at a dosage of 240 mg once daily, both before and after surgery, for a duration of 3 years.
Study NCT04524104 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lumen Treatment
Description: the virtual AI agent, Lumen, via an iPad-based application. Each participant will receive a locked, encrypted study iPad installed with Lumen. They will complete 8 problem solving therapy (PST) sessions beginning with 4 weekly and then 4 biweekly intervals over 12 weeks on their assigned iPad.
Study NCT04841044 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cetoleic acid
Description: Very long monounsaturated fatty acid ( C22:1n-11)
Study NCT04841044 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control Oil
Description: Control oil consisting of: mix of anchovy oil, olive oil, high-oleic sunflower oil and rapeseed oil
Study NCT04880343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Group (A)
Description: Group that will take a daily dose of the commercial dietary supplement provided by the sponsor, composed of mannose, cran-max and vitamin D for 6 months
Study NCT04880343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Group (B)
Description: Group that will take a daily dose of the commercial dietary supplement provided by the sponsor, composed of mannose, cran-max and vitamin D for 3 months
Study NCT05407363 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ABB and ATG with simultaneous implant placement
Description: Ridge augmentation using ABB and ATG as a graft material with simultaneous implant placement
Study NCT05407363 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: XBB and ATG with simultaneous implant placement
Description: Ridge augmentation using XBB and ATG as a graft material with simultaneous implant placement
Study NCT05407363 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ABB and ABG with simultaneous implant placement
Description: Ridge augmentation using ABB and ABG as a graft material with simultaneous implant placement
Study NCT05791721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoricoxib 90 Mg Oral Tablet
Description: Intervention will be applied one hour before surgical extraction of impacted mandibular third molar
Study NCT05791721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone 4mg
Description: Intervention will be applied one hour before surgical extraction of impacted mandibular third molar
Study NCT05124899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAP UnScented
Description: Sunscreen lip balm.
Study NCT05124899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAP Herbal Mint
Description: Sunscreen lip balm.
Study NCT05124899 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAP Mountain Berry
Description: Sunscreen lip balm.
Study NCT05124899 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SPF Standard Sunscreen
Description: SPF Standard (7 percent \[%\] Padimate-O and 3% Oxybenzone)
Study NCT04570085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine
Description: 100mg caffeine capsule treatment, beginning after caffeine diet during 6 weeks, titrate in 3 weeks (by 100mg stages) until 400mg aim dose per day in 2 doses during 27 weeks, and finally interrupt according to the same negative titration.
Study NCT04570085 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule treatment, beginning after caffeine diet during 6 weeks, titrate in 3 weeks until 2 doses aim dose per day during 27 weeks, and finally interrupt according to the same negative titration.
Study NCT05101109 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABL501
Description: ABL501 will be administered biweekly of every 28-day cycle in the dose-escalation. The dosing interval to be used in the dose-expansion part will be re-evaluated based on the emerging safety and PK data from the dose-escalation part of the study.
Study NCT04438551 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard dietary counseling
Description: Subjects will be given a low sodium diet handout with counseling, complete a validated questionnaire on low sodium foods, and complete a 24-hr urine collection.
Study NCT04438551 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard dietary counseling
Description: Subjects will be given a low sodium diet handout with counseling, complete a validated questionnaire on low sodium foods, and complete a 24-hr urine collection.
Study NCT04438551 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app
Description: Subjects will be given a low sodium diet handout with counseling, complete a validated questionnaire on low sodium foods, and complete a 24-hr urine collection. Subjects will be given a mobile app to build grocery lists where the sodium level will be recorded and tracked in the app.
Study NCT05261191 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MGD020
Description: MGD020 is a bispecific DART molecule that binds CD3 and gp41 subunit of HIV-1 envelope.
Study NCT05261191 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MGD014
Description: MGD014 is a bispecific DART molecule that binds CD3 and gp120 subunit of HIV-1 envelope.
Study NCT06632860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-TATE-RGD
Description: Intravenous injection of 68Ga-TATE-RGD with the dosage of 1.8-2.2 MBq (0.05-0.06 mCi)/kg. Tracer doses will be used to image lesions of by dual-targeted postive cancers PET/CT.
Study NCT06632860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18-FDG
Description: Intravenous injection of 18F-FDG with the dosage of 1.8-2.2 MBq(0.12-0.15mCi/kg). Tracer doses will be used to lesions therapy of dual-targeted postive cancers by SPECT/CT.
Study NCT05968521 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR): Experimental
Description: CR will consist of six sessions lasting 90 minutes of a structured exercise programme, educational and lifestyle modules, and a psychological component. Sessions include group discussions, experiential learning and homework tasks that participants are asked to complete between sessions. Participants in this treatment arm will also receive routine clinical outpatient management alongside CR.
Study NCT05968521 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual: Control
Description: Treatment as usual will include routine clinical outpatient management.
Study NCT05196529 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Description: All participants will undergo inspiratory muscle training.
Study NCT04186169 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Catheter ablation
Description: Catheter ablation
Study NCT05875545 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breathing Exercises
Description: Diaphragmatic breathing exercises with a physiotherapist for 8 weeks, two days a week